Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00033878 · ClinicalTrials.gov registry record · Phase 1
Study of Noni in Cancer Patients
A Phase 1 study, sponsored by National Center for Complementary and Integrative Health (NCCIH).
- Completed
- Registry status
- Phase 1
- Development phase
NCT00033878 is a Phase 1 study that has completed, run by National Center for Complementary and Integrative Health (NCCIH).
The verdict
NCT00033878, a Phase 1 study, has completed, sponsored by National Center for Complementary and Integrative Health (NCCIH).
- COMPLETED
- Registry status
- Phase 1
- Development phase
Study Summary
The purpose of this Phase 1 study is to: 1. determine the maximum tolerated dose of capsules containing 500mg of freeze dried noni fruit extract, 2. define toxicities associated with the ingestion of noni, 3. collect preliminary information on the efficacy of noni in respect to anti-tumor and symptom control properties to help select specific patients for subsequent Phase 2 studies, 4. identify chemical constituents of the extract that can be used to characterize the bioavailability and pharmacokinetics of noni food supplement.
Interventions
- DRUG Noni Extract
Trial Details
| Field | Value |
|---|---|
| Start Date | 2001-11 |
| Est. Completion | 2006-06 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00033878
The ClinicalTrials.gov registry entry for NCT00033878 describes a study currently listed as completed, categorized as Phase 1. An enrollment target was not published in the registry record, which is common for early-stage or observational entries. The listed sponsor is National Center for Complementary and Integrative Health (NCCIH), which has 203 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Noni Extract is the first listed.
NCT00033878 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00033878 about?
NCT00033878 is a clinical study titled "Study of Noni in Cancer Patients". The purpose of this Phase 1 study is to: 1. determine the maximum tolerated dose of capsules containing 500mg of freeze dried noni fruit extract, 2. define toxicities associated with the ingestion of noni, 3. collect preliminary information on the efficacy of noni in respect to anti-tumor and sympto...
What is the current status of trial NCT00033878?
This trial is currently completed. It is a Phase 1 study. The study started on 2001-11. Estimated completion is 2006-06.
What interventions are being tested in trial NCT00033878?
The interventions under investigation include: Noni Extract (DRUG).
Who is sponsoring clinical trial NCT00033878?
This trial is sponsored by National Center for Complementary and Integrative Health (NCCIH), which has 203 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.